Featured Issue Briefs

The Battle on the Home Front: Jonathan Gadsden's Story

The Battle on the Home Front: Jonathan Gadsden's Story

Marine Lance Corporal's story reflects the growing need for new antibiotics that can treat dangerous diseases, against which most drugs are useless. Read More

Facilitating Medical Device Innovation: De Novo Reform

Facilitating Medical Device Innovation: De Novo Reform

The de novo process -- which requests lower-risk reclassification of medical devices and entry into the marketplace -- as it exists now is not achieving its purpose and has instead added unnecessary and time-consuming requirements. Read More

Food Products Recalled by FDA

Food Products Recalled by FDA

Since President Obama signed the FDA Food Safety Modernization Act into law, at least 149 FDA-regulated food products have been recalled due to potential pathogenic contamination. Read More

More Issue Briefs

# results: 26-50 of 194
Show items per page
Date Issue Briefs Topic
Apr 30, 2009

No Economic Advantage to Industrialized Pork Production

In October 2008, a panel formed to conduct a comprehensive, fact-based examination of key aspects of the farm animal industry. The report found that the current industrial method of raising pigs for food carries no economic advantage over more natural pig farming. The researchers determined that when the costs to society and communities are taken into account – particularly the costs of waste treatment - industrial animal production actually carries a higher price tag.

More

Antibiotics in Food Animal Production

May 1, 2009

Testimony of Allan Coukell, Director of the Pew Prescription Project, on Protecting Consumers from Adulterated Drugs

Protecting consumers against the risk of adulterated products is, of course, the original mission of the FDA. Today, the vast majority of pharmaceutical products sold in the United States today are not adulterated, but an increasingly complex supply chain creates new challenges and new risks – as recent events demonstrate.

More

Drug Manufacturing and Distribution, Drug Safety

May 20, 2009

Curing Credit Card Penalties

Congress is set to enact new legislation that will make credit cards safer and more fair for consumers. As lawmakers negotiate final details before President Obama can sign the bill, new analysis from the Pew Health Group highlights the importance of a safeguard found only in the Senate’s version of the law.

More

Credit Cards

Jun 10, 2009

FDA Globalization Act of 2009: Drug Safety Provisions

The Food and Drug Administration Globalization Act of 2009 (H.R.759) seeks to secure the safety of imported prescription drugs and active pharmaceutical ingredients through greater FDA authority and manufacturer responsibility, and increased inspections of prescription drug and active pharmaceutical ingredient manufacturing sites abroad.

 

More

Drug Manufacturing and Distribution, Drug Safety

Jun 25, 2009

Regulatory Comment on Credit CARD Act Reasonable and Proportional Rule

The Pew Safe Credit Cards Project submitted comments to the Federal Reserve Board in regard to rulemaking under the Credit CARD Act of 2009. These comments focused specifically on the law’s requirement that penalty fees and charges must be reasonable and  proportional to related cardholder omissions or violations.

More

Credit Cards

Jul 2, 2009

Bill Summary - Counterfeit Drug Enforcement Act of 2009

This issue brief is a summary of H.R. 2726 - The Counterfeit Drug Enforcement Act of 2009, also known as the Tim Fagan Law.

More

Drug Safety, Medical Safety Policy

Jul 10, 2009

Bill Comparison - Regulation of Overseas Drug Manufacturing

This issue brief from the Pew Prescription Project outlines the differences between bills from the U.S. House of Representatives and the U.S. Senate regarding regulation of overseas drug manufacturing.

More

Drug Safety

Jul 15, 2009

Testimony: Robert P. Martin Before the U.S. House of Representatives Committee on Rules

Testimony from Robert P. Martin, Senior Officer, Pew Environment Group, before the U.S. House of Representatives Committee on Rules regarding the Preservation of Antibiotics for Medical Treatment Act (PAMTA).

More

Antibiotics in Food Animal Production

Jul 21, 2009

Pew letter to the FDA in response to their public recognition of animal agriculture's contribution to antimicrobial resistance

The Pew Campaign on Human Health and Industrial Farming (Pew) would like to extend our sincere thanks to you both for taking the time to meet with us on June 23 to discuss the contribution of animal agriculture to the growing public health crisis of antimicrobial resistance. We are deeply appreciative not only of your consideration of our viewpoints, but also the expertise and dedication that you bring to the U.S. Food and Drug Administration (FDA).

More

Antibiotics in Food Animal Production

Jul 24, 2009

Letter to the Assistant to the President for Domestic Policy

Our combined memberships include the country’s foremost scientific and medical experts and represent more than eleven million concerned Americans and health professionals. Our position is based on objective health interests and concerns that dangerous drug resistant infections are rapidly increasing in hospitals and community settings adding to the economic burden of the U.S. healthcare costs.

More

Antibiotics in Food Animal Production

Sep 21, 2009

Regulatory Comment on Credit CARD Act Rule: Advanced Notice and Cancel Requirements

The Pew Safe Credit Cards Project submitted comments (PDF) to the Federal Reserve Board regarding the Board’s interim final rules under Regulation Z (Docket No. R-1364). The rules cover advance notice and right to cancel requirements under the Credit CARD Act of 2009. Pew’s comments focused on a number of exceptions the Board proposed, which could allow issuers to raise interest rates, change minimum required payment levels and impose potentially large deferred interest charges with little or no advance warning.

More

Credit Cards

Sep 27, 2009

Letter from Danish Technical University Professor to Speaker Nancy Pelosi

We have just had the pleasure of meeting with a delegation consisting of four members of the House of Representatives, where we presented our data on the effects of the stop for nontherapeutic use of antimicrobials for food animals in Denmark.We know that various rumours and sometimes “creative” interpretations of what has taken place in Denmark have been circulated to members of the US Congress, and we are grateful for having been given this opportunity to correct some of these stories.

 

More

Antibiotics in Food Animal Production

Oct 7, 2009

Getting with the Program

This report  finds that nearly one in 10 community college students in the U.S. can’t get a federal loan if they need one because their schools choose not to participate in the federal loan programs. More

Consumer Financial Security

Nov 12, 2009

Children and Foodborne Illness

Children are disproportionately affected by foodborne illness, a serious public health problem. Approximately half of the reported foodborne illnesses occur in children. Every year, the Centers for Disease Control and Prevention (CDC) estimates that tens of millions of Americans fall ill, hundreds of thousands are hospitalized, and thousands die from foodborne illnesses.

More

Food Hazards

Nov 19, 2009

Regulatory Comment on Credit Card Disclosure Requirements

The Pew Safe Credit Cards Project submitted comments (PDF) to the Federal Reserve Board regarding the Board’s latest proposed rulemaking under Regulation Z (Docket No. R—1370). The rules implement provisions of the Credit CARD Act of 2009 that are effective February 22, 2010. Pew’s comments focused on clarifying the rights of consumers in a credit card contract and increased responsibility for and disclosure from credit card issuers.

More

Credit Cards

Dec 8, 2009

Letter from Danish Chief Veterinarian to Congress

In Denmark the termination of non-therapeutic use of antimicrobials for growth promotion has not caused any negative impact on the animal production. The Danish animal food industry has continued to improve its productivity and to increase its output.

More

Antibiotics in Food Animal Production

Dec 21, 2009

Capitol Hill Briefing: Industrial Animal Farms and Worker Health and Safety

On December 17, 2009, Pew hosted a briefing on Capitol Hill in collaboration with Rep. Raúl M. Grijalva, Co-Chair of the Congressional Progressive Caucus. Leading experts discussed the public health and sociological effects of industrial farm animal production for farm workers and rural communities.

More

Antibiotics in Food Animal Production

Feb 2, 2010

Charts Displaying Denmark's Decline in Antibiotic Resistance

These charts summarize Denmark's decline in antibiotic usage and antibiotic resistance, as well as the increase of livestock and poultry production after a ban on the nontheraputic use of antibiotics and antimicrobial drugs in food production animals.

More

Antibiotics in Food Animal Production

Feb 8, 2010

Important Human Medicines Used on Industrial Farms

Industrial animal farms commonly administer low doses of antibiotics and other antimicrobials (drugs that fight microorganisms like bacteria and viruses) to pigs, cows, chickens, sheep, and other food animal species for the purpose of growth promotion or weight gain. Typically, these sub-therapeutic doses, which are generally not high enough to fight active diseases or infections, are given directly to animals in their feed or water.

More

Antibiotics in Food Animal Production

Feb 8, 2010

Food Safety and the Antibiotic Resistance Crisis

According to a first-ever study by professors at the University of Regina in the United Kingdom, U.S. food safety ranks seventh or “average” among 17 other industrialized nations. At least 76 million cases of food-borne disease occur each year in the U.S. While many health problems caused by contaminated food are not serious, some food-borne infections are much more dangerous, leading to convulsions, premature delivery and miscarriage, sepsis, or even death.

More

Antibiotics in Food Animal Production

Feb 8, 2010

Antibiotic Resistance and the Industrial Animal Farm

Antibiotics are commonly prescribed drugs that kill bacteria or suppress their ability to grow, allowing the human immune system to respond and heal from illness. Antibiotic resistance is a dangerous bacterial trait which enables bacteria to survive and continue to grow instead of being inhibited or destroyed by therapeutic doses of the drug. As a result, antibiotic-resistant bacteria can evade the effects of the antibiotic and multiply, with severe consequences for human health.

More

Antibiotics in Food Animal Production

Feb 8, 2010

Antibiotic-Resistant Bacteria in Animals and Unnecessary Human Health Risks

In the United States, many food animals—poultry, swine and cattle—are routinely treated with antibiotics in order to grow animals faster and to compensate for unsanitary conditions on many industrial farms. Recently, major increases in antibiotic-resistant bacterial infections in human populations have led to public health concerns regarding antibiotic use for non-therapeutic purposes (i.e., not used to treat disease) in animals destined for food production.

More

Antibiotics in Food Animal Production

Feb 8, 2010

Industrial Farms and Antibiotic Resistance

Basic information on antibiotics, their use on industrial animal farms, and the problem of antibiotic resistance from the Pew Campaign on Human Health and Industrial Farming.

More

Antibiotics in Food Animal Production

Feb 19, 2010

Produce Safety Project: Stakeholders' Discussion Series Meetings

The Food and Drug Administration announced in December 2009, that it was going to establish a nationwide produce safety standard for the growing, harvesting and packing of fresh fruits and vegetables and opened an official docket for comments in February 2010. More

Food Safety

Feb 22, 2010

Moving Towards Safer Credit Cards

On February 22, major new consumer protections took effect as part of the second implementation phase of the Credit Card Accountability, Responsibility, and Disclosure (CARD) Act of 2009. Just two practices addressed in this second phase will save American consumers at least $10 billion a year. The Pew Health Group's Safe Credit Cards Project is looking ahead to the third and final phase of the Credit CARD Act, to take effect August 22, 2010, which will require all credit card penalties to be “reasonable and proportional” and will direct card issuers to review all interest rate increases since the beginning of 2009.

More

Credit Cards